Market Cap: $3.3681T 1.190%
Volume(24h): $82.0486B 24.680%
  • Market Cap: $3.3681T 1.190%
  • Volume(24h): $82.0486B 24.680%
  • Fear & Greed Index:
  • Market Cap: $3.3681T 1.190%
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
Top News
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
bitcoin
bitcoin

$108166.236572 USD

0.05%

ethereum
ethereum

$2515.590590 USD

-0.11%

tether
tether

$1.000285 USD

-0.01%

xrp
xrp

$2.216184 USD

-0.32%

bnb
bnb

$655.165841 USD

0.05%

solana
solana

$147.119253 USD

-0.66%

usd-coin
usd-coin

$1.000016 USD

0.00%

tron
tron

$0.283596 USD

0.48%

dogecoin
dogecoin

$0.163766 USD

0.36%

cardano
cardano

$0.572467 USD

-0.10%

hyperliquid
hyperliquid

$39.371467 USD

0.63%

sui
sui

$2.897088 USD

0.28%

bitcoin-cash
bitcoin-cash

$487.010658 USD

0.33%

chainlink
chainlink

$13.191270 USD

-0.04%

unus-sed-leo
unus-sed-leo

$9.039695 USD

-0.03%

Cryptocurrency News Articles

SingularityNET and Rejuve.Bio to Showcase Cell Rejuvenation Advancements at Demo Day

Mar 23, 2024 at 09:45 am

SingularityNET and Rejuve.Bio are co-hosting a Demo Day on March 27th at 19:30 UTC via Zoom, featuring Rejuve.Bio's CEO, Kennedy Schaal, and their business strategist, Ed Brennan. They will discuss the company's latest developments and strategies. SingularityNET is a blockchain-based marketplace and framework for AI services, allowing users to create, share, and monetize AI services using the AGI token.

SingularityNET and Rejuve.Bio to Showcase Cell Rejuvenation Advancements at Demo Day

SingularityNET Hosts Demo Day with Rejuve.Bio

London, March 22, 2023 - SingularityNET, a blockchain-based marketplace and framework for artificial intelligence (AI) services, is hosting a Demo Day in collaboration with Rejuve.Bio, a biotechnology company specializing in the rejuvenation and repair of cells and tissues. The event will take place on Zoom on March 27th at 19:30 UTC.

Kennedy Schaal, CEO of Rejuve.Bio, and Ed Brennan, the company's business strategist, will present at the event. They will provide an in-depth overview of Rejuve.Bio's cutting-edge research and advancements in the field of cellular rejuvenation. Attendees will gain insights into the company's innovative strategies and collaborations that are driving the development of novel therapies for age-related diseases.

Dr. Ben Goertzel, Founder and CEO of SingularityNET, emphasized the importance of this collaboration. He stated, "Rejuve.Bio's mission to address the fundamental challenges of aging aligns seamlessly with SingularityNET's goal of leveraging AI to empower human potential. Their groundbreaking work has the potential to revolutionize healthcare and extend the healthy human lifespan."

SingularityNET is a platform that enables organizations and individuals to create, share, and monetize AI services. It provides access to a wide range of AI algorithms, services, and agents, allowing developers to contribute their own models and earn AGI (Artificial General Intelligence) tokens. By decentralizing AI services, SingularityNET aims to reduce reliance on tech giants and foster a dynamic marketplace for innovation.

The Demo Day will provide a unique opportunity for stakeholders in the AI and biotechnology sectors to engage with experts from Rejuve.Bio. Attendees will have the chance to ask questions, gain insights into the latest research, and explore potential collaborations.

To register for the Demo Day, visit the official SingularityNET website: [Website URL]

Disclaimer:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

Other articles published on Jul 07, 2025